ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 112 filers reported holding ACCELERON PHARMA INC in Q3 2015. The put-call ratio across all filers is 2.48 and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $243,000 | -56.5% | 0 | -100.0% | 1.87% | +7.8% |
| Q1 2017 | $559,000 | -5.9% | 21,106 | -9.3% | 1.73% | -17.6% |
| Q4 2016 | $594,000 | +75.7% | 23,272 | +148.9% | 2.10% | +149.1% |
| Q3 2016 | $338,000 | +6.3% | 9,351 | 0.0% | 0.84% | +34.0% |
| Q2 2016 | $318,000 | +28.7% | 9,351 | 0.0% | 0.63% | +33.8% |
| Q1 2016 | $247,000 | -45.8% | 9,351 | 0.0% | 0.47% | -37.9% |
| Q4 2015 | $456,000 | -27.3% | 9,351 | -62.9% | 0.76% | -38.6% |
| Q3 2015 | $627,000 | -21.3% | 25,194 | 0.0% | 1.24% | +22.4% |
| Q2 2015 | $797,000 | +23.2% | 25,194 | +48.2% | 1.01% | -16.7% |
| Q1 2015 | $647,000 | -23.2% | 16,996 | -21.3% | 1.21% | -41.9% |
| Q4 2014 | $842,000 | – | 21,603 | – | 2.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |